Suppr
超能文献

Adynamic bone disease-bone and beyond.

作者信息

Brandenburg Vincent M, Floege Jürgen

机构信息

Department of Nephrology and Clinical Immunology , RWTH University Hospital Aachen , Pauwelsstrasse 30, Aachen, D-52057 , Germany.

出版信息

NDT Plus. 2008 Jun;1(3):135-47. doi: 10.1093/ndtplus/sfn040.

DOI:10.1093/ndtplus/sfn040

PMID:25983860

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4421169/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159a/4421169/6cece54e466a/sfn040fig1.jpg

相似文献

Adynamic bone disease-bone and beyond.

NDT Plus. 2008 Jun;1(3):135-47. doi: 10.1093/ndtplus/sfn040.

Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate.

Histopathology. 2001 Jun;38(6):571-83. doi: 10.1046/j.1365-2559.2001.01139.x.

[Chronic kidney disease-mineral and bone disorder (CKD-MBD)].

Nihon Rinsho. 2006 Sep;64(9):1703-6.

Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease.

Kidney Int. 2015 May;87(5):1039-45. doi: 10.1038/ki.2014.372. Epub 2014 Dec 10.

Adynamic bone disease: clinical and therapeutic implications.

Curr Opin Nephrol Hypertens. 2009 Jul;18(4):303-7. doi: 10.1097/MNH.0b013e32832c4df0.

Risk of adynamic bone disease in dialyzed patients.

Kidney Int Suppl. 1992 Oct;38:S62-7.

Adynamic bone disease is a predominant bone pattern in early stages of chronic kidney disease.

J Nephrol. 2017 Oct;30(5):629-634. doi: 10.1007/s40620-017-0397-7. Epub 2017 Apr 12.

Development, validation and characterization of a novel mouse model of Adynamic Bone Disease (ABD).

Bone. 2014 Nov;68:57-66. doi: 10.1016/j.bone.2014.07.037. Epub 2014 Aug 8.

Variant of adynamic bone disease in hemodialysis patients: fact or fiction?

Am J Kidney Dis. 2006 Sep;48(3):430-6. doi: 10.1053/j.ajkd.2006.05.028.

Effects of treatment of renal osteodystrophy on bone histology.

Clin J Am Soc Nephrol. 2008 Nov;3 Suppl 3(Suppl 3):S157-63. doi: 10.2215/CJN.02500607.

引用本文的文献

Adynamic bone disorder in chronic kidney disease: meta-analysis and narrative review of potential biomarkers as diagnosis and therapeutic targets.

Ren Fail. 2025 Dec;47(1):2530162. doi: 10.1080/0886022X.2025.2530162. Epub 2025 Jul 16.

Treatment of Osteoporosis in Patients with Chronic Kidney Disease.

Curr Osteoporos Rep. 2025 Jun 2;23(1):26. doi: 10.1007/s11914-025-00919-0.

Chronic kidney disease mineral bone disorder in childhood and young adulthood: a 'growing' understanding.

Pediatr Nephrol. 2024 Mar;39(3):723-739. doi: 10.1007/s00467-023-06109-3. Epub 2023 Aug 25.

Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis.

Front Physiol. 2023 Jun 5;14:1177829. doi: 10.3389/fphys.2023.1177829. eCollection 2023.

Newly diagnosed metastatic pulmonary calcification in a kidney transplantation recipient: a case report.

Korean J Transplant. 2022 Dec 31;36(4):278-282. doi: 10.4285/kjt.22.0026. Epub 2022 Sep 15.

To evaluate the relationship between serum magnesium and parathyroid hormone levels in peritoneal dialysis and hemodialysis patients.

Int Urol Nephrol. 2023 May;55(5):1321-1327. doi: 10.1007/s11255-022-03445-5. Epub 2022 Dec 16.

Is Adynamic Bone Always a Disease? Lessons from Patients with Chronic Kidney Disease.

J Clin Med. 2022 Nov 30;11(23):7130. doi: 10.3390/jcm11237130.

Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future.

Nutrients. 2022 Jul 22;14(15):3009. doi: 10.3390/nu14153009.

Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients.

World J Surg. 2022 Apr;46(4):813-819. doi: 10.1007/s00268-022-06439-7. Epub 2022 Jan 12.

Adynamic bone disease.

J Bras Nefrol. 2021 Dec 3;43(4 Suppl 1):650-653. doi: 10.1590/2175-8239-JBN-2021-S108. eCollection 2021.

本文引用的文献

Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.

J Am Soc Nephrol. 2008 Feb;19(2):405-12. doi: 10.1681/ASN.2006101089. Epub 2008 Jan 16.

Kidney Int. 2008 Mar;73(6):771-7. doi: 10.1038/sj.ki.5002769. Epub 2008 Jan 9.

Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease.

Clin J Am Soc Nephrol. 2007 Nov;2(6):1255-60. doi: 10.2215/CJN.03461006. Epub 2007 Oct 17.

A sensitive stain for aluminum in undecalcified cancellous bone.

J Inorg Biochem. 2007 Sep;101(9):1285-90. doi: 10.1016/j.jinorgbio.2007.06.006. Epub 2007 Jun 12.

Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.

Bone. 2007 Oct;41(4):698-703. doi: 10.1016/j.bone.2007.06.014. Epub 2007 Jun 29.

Mineral metabolism disturbances in patients with chronic kidney disease.

Eur J Clin Invest. 2007 Aug;37(8):607-22. doi: 10.1111/j.1365-2362.2007.01840.x.

Vascular calcification and fetuin-A deficiency in chronic kidney disease.

Trends Cardiovasc Med. 2007 May;17(4):124-8. doi: 10.1016/j.tcm.2007.02.005.

Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol.

Nat Clin Pract Nephrol. 2007 Apr;3(4):227-32. doi: 10.1038/ncpneph0443.

Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study.

Ther Apher Dial. 2007 Apr;11(2):121-30. doi: 10.1111/j.1744-9987.2007.00419.x.

Vascular calcification and disordered mineral metabolism in dialysis patients.

Semin Dial. 2007 Mar-Apr;20(2):139-43. doi: 10.1111/j.1525-139X.2007.00261.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Adynamic bone disease-bone and beyond.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译